Studies

The PCCTC’s trial portfolio represents a substantial proportion of industry-sponsored and NIH-sponsored prostate cancer trials open in the US, characterizing a substantial presence in this research space. Our studies span the entire prostate cancer disease continuum and are strategically aligned with the Consortium’s own pathway-based scientific programs and a parallel commitment to the co-development of trial endpoints and biomarkers. Patient advocacy efforts are supported by Cancer ABCs.

Our Active Study Portfolio

Recent News +++

Follow Us

RT @CancerPromise: Learn more about @ThePCCTC's @CancerPromise!
Mark your calendar! Featuring a stellar expert panel, the next ENGAGEMENT Study Virtual Genetics Board will air on… https://t.co/04blbOvAdZ
RT @DrRanaMcKay: Join us tonight for the @SoMeCME discussing ADT management in prostate cancer. @PBarataMD @shilpaonc @Daniel_J_George @Bra…

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

careers.mskcc.org

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.